Cigna projects AI tools will save $200 million over three years. The company also invests $100 million through 2028 to cut clinician work.
A campaign using AI insights led over 80% to choose cheaper biosimilars.
This helps Cigna manage costs amid rising national health spending.
What happened
Cigna projects its AI and predictive analytics tools, used to identify chronic conditions like cancer and kidney disease, will save an estimated $200 million over the next three years by proactively connecting patients with clinicians. The company also announced a $100 million investment through 2028 to reduce clinician documentation time and speed up prescriptions.
Why it matters
These savings are critical for Cigna, which generates $275 billion in annual revenue and ranks 14th on the latest Fortune 500 list, as national healthcare spending exceeds $5 trillion annually. A targeted campaign using AI insights led more than 80% of patients to opt for a biosimilar over a costly biologic, creating hundreds of millions in savings for patients.
What to watch
Cigna's AI chief emphasizes personalization and proactive care, and the company is partnering with major AI players like OpenAI and Anthropic. One deployed AI tool has reduced note-taking by up to 90% for practitioners in its telehealth service MDLIVE.
Ask the AI about this article →
Cigna's AI strategy, led by Katya Andresen, focuses on measuring how AI can change health outcomes rather than chasing use cases. The company's investments are partly a response to rising national healthcare spending, which exceeds $5 trillion annually. By using AI to improve patient engagement and reduce clinician workload, Cigna aims to cut costs and address patient frustration with the complex system.
Andresen, who joined in September 2021, has emphasized partnerships with big AI players like OpenAI and Anthropic, as well as startups like Sierra for specific use cases. Cigna has also deployed internal tools, including an AI virtual assistant in its mobile app and AI-enabled summarization that cut note-taking by up to 90% for MDLIVE practitioners. The company's compliance framework, built over a decade, helps manage sensitive patient data.
Looking ahead, Andresen envisions AI in healthcare becoming conversational, ambient, and more proactive, allowing for more precise treatments and recommendations. However, the article notes rising questions about guardrails for AI chatbots handling sensitive information. Cigna's regulated status provides a foundation, but as AI evolves, maintaining accuracy and privacy will remain critical.
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytime
Ask AI anything about this article. Q&As are published on this page for other readers too.
On August 25, 2026, OpenAI unveiled Jalapeño, its first custom inference chip, claiming 1.5–1.9x more AI work…
The Linux Foundation announced the contribution of TRACE (Trust, Runtime Attestation and Compliance Evidence)…
A new Stanford research paper warns that AI chatbots and agents may let advertising dollars influence what the…
The Wall Street Journal published an op-ed by billionaire investor Stanley Druckenmiller that was written with…
OpenAI unveiled benchmarks for its Jalapeño inference chip on Tuesday, showing it competes with Nvidia’s best…
Researchers from Bytedance Seed developed EdgeBench, a benchmark measuring how AIs improve on tasks over multi…
